Durvalumab vs Losartan

## Durvalumab vs Losartan: Overview

This comparison examines the pharmacological differences between **Durvalumab** and **Losartan**.

## Mechanism of Action

**Durvalumab**: Human IgG1 kappa anti-PD-L1 monoclonal antibody blocking PD-L1 binding to PD-1 and CD80.

**Losartan**: Angiotensin II receptor type 1 antagonist.

## Pharmacokinetics

**Half-life**: Durvalumab — 17 days; Losartan — 2 hours.

## Chemical Properties

**Molecular Formula**: Durvalumab — N/A; Losartan — C22H23ClN6O.

**Molecular Weight**: Durvalumab — N/A; Losartan — 422.9200 g/mol.

**Type**: Durvalumab — Antibody; Losartan — Small molecule.